J.-C. Lin

861 total citations
19 papers, 681 citations indexed

About

J.-C. Lin is a scholar working on Oncology, Epidemiology and Rheumatology. According to data from OpenAlex, J.-C. Lin has authored 19 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in J.-C. Lin's work include Viral-associated cancers and disorders (10 papers), Eosinophilic Disorders and Syndromes (6 papers) and Antibiotic Resistance in Bacteria (5 papers). J.-C. Lin is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Eosinophilic Disorders and Syndromes (6 papers) and Antibiotic Resistance in Bacteria (5 papers). J.-C. Lin collaborates with scholars based in Taiwan, United States and Türkiye. J.-C. Lin's co-authors include Joseph S. Pagano, Erik De Clercq, James Kamine, Elizabeth Holley-Guthrie, Shannon C. Kenney, L. Kristopher Siu, Feng‐Yee Chang, Chang‐Phone Fung, J S Pagano and Po‐Liang Lu and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J.-C. Lin

19 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-C. Lin Taiwan 14 276 230 190 184 106 19 681
Jason P. Trama United States 19 86 0.3× 386 1.7× 25 0.1× 142 0.8× 55 0.5× 30 935
Maria Angela Biasolo Italy 16 137 0.5× 330 1.4× 36 0.2× 182 1.0× 26 0.2× 25 690
F Forestier France 13 53 0.2× 220 1.0× 25 0.1× 179 1.0× 29 0.3× 46 859
Wan‐Shik Shin South Korea 16 129 0.5× 249 1.1× 76 0.4× 200 1.1× 9 0.1× 37 583
Andrés Obregón‐Henao United States 21 61 0.2× 543 2.4× 84 0.4× 763 4.1× 101 1.0× 45 1.2k
L. Peroni Italy 11 61 0.2× 139 0.6× 55 0.3× 73 0.4× 12 0.1× 15 554
Kamlesh Bhatt United States 14 80 0.3× 379 1.6× 86 0.5× 547 3.0× 19 0.2× 23 813
Pairote Laochumroonvorapong United States 9 76 0.3× 425 1.8× 29 0.2× 497 2.7× 16 0.2× 12 893
Peechanika Chopjitt Thailand 13 55 0.2× 97 0.4× 131 0.7× 75 0.4× 22 0.2× 53 554
Hisashi FUNADA Japan 11 60 0.2× 113 0.5× 31 0.2× 141 0.8× 13 0.1× 56 412

Countries citing papers authored by J.-C. Lin

Since Specialization
Citations

This map shows the geographic impact of J.-C. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-C. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-C. Lin more than expected).

Fields of papers citing papers by J.-C. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-C. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-C. Lin. The network helps show where J.-C. Lin may publish in the future.

Co-authorship network of co-authors of J.-C. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of J.-C. Lin. A scholar is included among the top collaborators of J.-C. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-C. Lin. J.-C. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yang, Ya‐Sung, Chun-Hsiang Chiu, Ti Yin, et al.. (2015). Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure. Clinical Microbiology and Infection. 21(8). 758–764. 12 indexed citations
2.
Huang, Tur‐Fu, et al.. (2015). Applying ATP bioluminescence to design and evaluate a successful new intensive care unit cleaning programme. Journal of Hospital Infection. 90(4). 344–346. 10 indexed citations
3.
Sun, Jun‐Ren, Cherng‐Lih Perng, J.-C. Lin, et al.. (2014). AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii. European Journal of Clinical Microbiology & Infectious Diseases. 33(12). 2141–2147. 34 indexed citations
4.
Yang, Ya‐Sung, et al.. (2014). Clinical manifestations and prognostic factors of Morganella morganii bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. 34(2). 231–236. 36 indexed citations
5.
Chen, Ying-Tsong, J.-C. Lin, Chang‐Phone Fung, et al.. (2013). KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. Journal of Antimicrobial Chemotherapy. 69(3). 628–631. 70 indexed citations
6.
Stewart, Paul W., et al.. (2012). Cantharidin for the Treatment of Molluscum Contagiosum: A Prospective, Double‐Blinded, Placebo‐Controlled Trial. Pediatric Dermatology. 31(4). 440–449. 27 indexed citations
7.
Chen, Jiann‐Hwa, et al.. (2010). Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 65(5). 986–990. 63 indexed citations
8.
Lin, J.-C., et al.. (2001). Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia.. PubMed. 34(2). 131–7. 10 indexed citations
9.
Chao, Tai-Jong, et al.. (2000). Scrub Typhus-Associated Hemophagocytic Syndrome. Infection. 28(3). 178–179. 29 indexed citations
10.
11.
Lin, J.-C., et al.. (1989). Synergistic Inhibition of Epstein-Barr Virus: Transformation of B Lymphocytes by   and   Interferon and by 3'-Azido-3'-Deoxythymidine. The Journal of Infectious Diseases. 159(2). 248–254. 21 indexed citations
12.
Kenney, Shannon C., et al.. (1989). The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. Journal of Virology. 63(4). 1729–1736. 116 indexed citations
13.
Lin, J.-C., et al.. (1988). Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus. Antimicrobial Agents and Chemotherapy. 32(2). 265–267. 26 indexed citations
14.
15.
Lin, J.-C., Erik De Clercq, & Joseph S. Pagano. (1987). Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrobial Agents and Chemotherapy. 31(9). 1431–1433. 65 indexed citations
16.
17.
Lin, J.-C., et al.. (1985). Effect of (E)-5-(2-Bromovinyl)-2′-deoxyuridine on replication of Epstein-Barr Virus in human lymphoblastoid cell lines. Antiviral Research. 5. 121–126. 10 indexed citations
18.
19.
Pagano, Joseph S., et al.. (1983). Acyclovir and Epstein--Barr virus infection. Journal of Antimicrobial Chemotherapy. 12(suppl B). 113–121. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason P. Trama Breakdown of academic impact, for papers by Maria Angela Biasolo Breakdown of academic impact, for papers by F Forestier Breakdown of academic impact, for papers by Wan‐Shik Shin Breakdown of academic impact, for papers by Andrés Obregón‐Henao Breakdown of academic impact, for papers by L. Peroni Breakdown of academic impact, for papers by Kamlesh Bhatt Breakdown of academic impact, for papers by Pairote Laochumroonvorapong Breakdown of academic impact, for papers by Peechanika Chopjitt Breakdown of academic impact, for papers by Hisashi FUNADA
Rankless by CCL
2026